Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02713373
Title Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Roswell Park Cancer Institute
Indications

colorectal cancer

Therapies

Cetuximab + Pembrolizumab

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST